Skip to main content

Table 2 Retrospective cohort: second-line chemotherapy used

From: Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

Chemotherapy regimen n. (%)
Monotherapy with 5-fluorouracil or capecitabine 49 (28)
Gemcitabine plus 5-fluorouracil or capecitabine 38 (22)
Capecitabine plus mytomicin-C 21 (12)
FOLFIRI or XELIRI 17 (10)
Retreatment with gemcitabine plus cisplatin or oxaliplatin 13 (7)
FOLFOX or XELOX 10 (6)
Epirubicin plus cisplatin plus 5-fluorouracil 9 (5)
Gemcitabine plus irinotecan 6 (3)
Monotherapy with gemcitabine 4 (2)
Other regimens 7 (4)
  1. Abbreviations: n number, FOLFIRI 5-fluorouracil plus irinotecan, XELIRI capecitabine plus irinotecan, FOLFOX 5-fluorouracil plus of oxaliplatin, XELOX capecitabine plus oxaliplatin